Search Prime Grants

UG1EY029657

Cooperative Agreement

Overview

Grant Description
Spectacle prescribing in early childhood (SPEC)
Funding Goals
1) TO SUPPORT EYE AND VISION RESEARCH PROJECTS THAT ADDRESS THE LEADING CAUSES OF BLINDNESS AND IMPAIRED VISION IN THE U.S. THESE INCLUDE RETINAL DISEASES, CORNEAL DISEASES, CATARACT, GLAUCOMA AND OPTIC NEUROPATHIES, STRABISMUS, AMBLYOPIA, AND LOW VISION AND BLINDNESS REHABILITATION. 2) TO INCREASE UNDERSTANDING OF THE NORMAL DEVELOPMENT AND FUNCTION OF THE VISUAL SYSTEM IN ORDER TO BETTER PREVENT, DIAGNOSE, AND TREAT SIGHT-THREATENING CONDITIONS, AND, TO ENHANCE THE REHABILITATION, TRAINING, AND QUALITY OF LIFE OF INDIVIDUALS WHO ARE PARTIALLY-SIGHTED OR BLIND. 3) TO SUPPORT A BROAD PROGRAM OF BASIC VISION RESEARCH THROUGH GRANTS AND COOPERATIVE AGREEMENTS, TO ENCOURAGE HIGH QUALITY CLINICAL RESEARCH, INCLUDING CLINICAL TRIALS, OTHER EPIDEMIOLOGICAL STUDIES, AND HEALTH SERVICES RESEARCH, TO ENCOURAGE RESEARCH TRAINING AND CAREER DEVELOPMENT IN THE SCIENCES RELATED TO VISION, AND TO SPONSOR SCIENTIFIC WORKSHOPS IN HIGH PRIORITY RESEARCH AREAS TO ENCOURAGE EXCHANGE OF INFORMATION AMONG SCIENTISTS. 4) SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO ENCOURAGE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Arizona United States
Geographic Scope
State-Wide
Analysis Notes
Amendment Since initial award the End Date has been extended from 05/31/24 to 05/31/26 and the total obligations have increased 679% from $788,814 to $6,147,745.
University Of Arizona was awarded Spectacle Prescribing in Early Childhood (SPEC) Cooperative Agreement UG1EY029657 worth $6,147,745 from National Eye Institute in June 2019 with work to be completed primarily in Arizona United States. The grant has a duration of 7 years and was awarded through assistance program 93.867 Vision Research. The Cooperative Agreement was awarded through grant opportunity NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required).

Status
(Ongoing)

Last Modified 7/21/25

Period of Performance
6/1/19
Start Date
5/31/26
End Date
89.0% Complete

Funding Split
$6.1M
Federal Obligation
$0.0
Non-Federal Obligation
$6.1M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to UG1EY029657

Subgrant Awards

Disclosed subgrants for UG1EY029657

Transaction History

Modifications to UG1EY029657

Additional Detail

Award ID FAIN
UG1EY029657
SAI Number
UG1EY029657-3027958594
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NW00 NIH National Eye Institute
Funding Office
75NW00 NIH National Eye Institute
Awardee UEI
ED44Y3W6P7B9
Awardee CAGE
0LJH3
Performance District
AZ-90
Senators
Kyrsten Sinema
Mark Kelly

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Eye Institute, National Institutes of Health, Health and Human Services (075-0887) Health research and training Grants, subsidies, and contributions (41.0) $6,477,780 100%
Modified: 7/21/25